In a first-of-its-kind analysis, Cornell researchers and partners at the Clinton Health Access Initiative found that pharmaceutical producers could reduce their environmental impact by roughly half by optimizing manufacturing processes and supply chain networks and by switching to renewable energy sources. Read more
A Cornell-led collaboration harnessed chemical reactions to make microscale origami machines self-fold – freeing them from the liquids in which they usually function, so they can operate in dry environments and at room temperature. Read more
Robert Langer ’70, whose pioneering work in biotechnology, drug delivery and tissue engineering has made him one of the most prolific inventors in medicine, received the Cornell Engineering Distinguished Alumni Award during a celebration hosted April 19. Read more
Using a biomaterials-based organoid, a multi-institution team led by Matt DeLisa of Cornell Engineering was able to assess the strength of the immune response to a glycoengineered vaccine in days, instead of months. Read more
As automobile electrification speeds up, the world faces a need for critical metals to make these vehicles possible, with high demand setting off economic snags and supply-chain hitches. Read more
A recent technology feature in the journal Nature highlighted the work of CBE Professor Matt DeLisa, the William L. Lewis Professor of Engineering and Director of the Cornell Institute of Biotechnology. The story, “How cell-free processes could speed up vaccine development,” discusses the ongoing efforts of bioengineers, including DeLisa and his team, to discover cheaper and easier ways to make proteins and other complex biomolecules. Antibodies, for instance, have become the bread and butter for many pharmaceutical companies, and DeLisa says that the ability to synthesize these molecules... Read more
Endowed chairs are the highest faculty honor at Cornell. Read more
Election is among the highest professional distinctions accorded to a medical and biological engineer. Read more
